FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies
New findings from University of Virginia, Asthma and Allergic Disease Center in the area of allergies published
March 15th, 2007
A report, "T-cell responses to allergens," is newly published data in The Journal of Allergy and Clinical Immunology. "The allergic response in human beings is engineered by CD4(+) T lymphocytes, which secrete T(H)2 cytokines in response to activation by allergen-derived peptides. Although T(H)2 cells have been well characterized, defining the properties of allergen-specific T cells has proved challenging in human beings because of their low frequency within the T-cell repertoire," scientists writing in the Journal of Allergy and Clinical Immunology report. "However, recent studies have provided insight into the molecular signature of long-lived human memory...
Source: FDA Law Weekly (2007-03-15)
|
